SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.31 CNY | -3.48% |
|
+0.97% | -22.41% |
ETFs positioned on Shanghai Hile Bio-Technology Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +3.39% | - |
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. is principally engaged in the research & development, production and sales of veterinary biological products. The Companyâs products mainly include escherichia coli (K88 and K99) gene modified vaccines for piglets, inactivated; porcine reproductive and respiratory syndrome vaccines, live and swine infectious atrophic rhinitis vaccines, inactivated; newcastle disease mild vaccines, living; newcastle disease, infectious bronchitis, egg drop syndromeâ76 vaccines, inactivated and infectious bronchitis vaccines, living, among others. The Company distributes its products mainly in China.
Sector
Pharmaceuticals
Calendar
23/05/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -22.41% | 784M | |
| -14.93% | 77.13B | |
| +26.62% | 3.79B | |
| -0.14% | 3.22B | |
| +16.05% | 1.64B | |
| -7.99% | 1.5B | |
| -22.43% | 1.3B | |
| -4.69% | 1.25B | |
| -9.08% | 1.18B | |
| +5.25% | 1.1B |
- Stock Market
- Equities
- 603718 Stock
- Funds and ETFs Shanghai Hile Bio-Technology Co., Ltd.